APOLLO is a clinical framework to assure quality data by providing a structure that accelerates research-driven patient care.

Spring 2017 : About the Adaptive Patient-Oriented Longitudinal Learning and Optimization (APOLLO) platform

About the Adaptive Patient-Oriented Longitudinal Learning and Optimization (APOLLO) platform

APOLLO, part of MD Anderson's Moon Shots Program™, is a clinical framework to assure quality data by providing a structure that accelerates research-driven patient care.

APOLLO has a streamlined and standardized process for:

gathering high-quality biopsies and conducting biospecimen draws before, during and at the end of treatment
preparing samples for deep genomic/molecular analysis and immune response monitoring
storing results in the Translational Research Accelerator platform, which is the first and currently only truly integrated clinical and research data platform made for cancer research

APOLLO has been used successfully in leukemia, sarcoma and melanoma pilot projects. In the next two years, it is scheduled to conduct analyses in 2,100 patients enrolled on 28 high-priority clinical trials for lung, breast, colorectal, pancreas, ovarian and HPV-related cancers, as well as multiple myeloma, glioblastoma, lymphoma and sarcoma.

APOLLO has standard-changing potential. The platform will enable deep longitudinal molecular profiling of even the rarest cancers, populating the most comprehensive, patient-centric and clinically driven molecular cancer dataset anywhere.

Andy Futreal, Ph.D., professor, Genomic Medicine
Cynthia Powers, director of Ambulatory Work Standardization

More Stories From Promise

Cancer prevention efforts in full swing

MD Anderson aims for greater reach at Shell Houston Open

A legacy of impact and innovation

MD Anderson's fourth president turns focus to cancer research, advocacy

A cancer survivor's cross-country battle

Cancer survivor travels coast to coast post-cancer treatment to raise awareness of HPV-related cancers

Peace of mind for MD Anderson patients

$100,000 gift provides support for patients' unthought-of needs

Survivors Say: Karlee Steele

Karlee Steele, of Austin, is a three-time cancer survivor. She enjoys hiking and fishing with her son, Quade, 11. She has been with Cox Media Group for 10 years, first in El Paso and now in Austin, where she is a sales manager.

iPromise: Brendan Locke

Brendan Locke and his wife, Melissa, of Milwaukee, recently worked with the state of Wisconsin to declare July as Sarcoma Awareness Month. They are actively involved with the CancerHawk Foundation.